Friday, November 15, 2013
7:15 a.m.                  Registration and Continental Breakfast
8:00 a.m.                  Opening Remarks                                                                                                                       
                                        Matthew Ringel, MD and Jennifer Sipos, MD
SESSION ONE: Defining Pathways of Thyroid Cancer: Predisposition, Development and
Session Chair: Matthew Ringel, MD

     New Advances in Defining Signaling Pathways in Thyroid Cancer
     Formation, Progression and Therapeutic Responses
8:10-8:45 a.m.        Defining New BRAF Pathways in Thyroid Cancer Progression
                                           Matthew Ringel, MD
8:50-9:40 a.m.         Identification and Validation of New Gene Rearrangements in Papillary Thyroid Cancer 
                                           Yuri Nikiforov, MD

9:45-10:20 a.m.      Regulation of Radioiodine Accumulation in Thyroid Cancer: Translational Studies
                                            Sissy Jhiang, PhD

10:25-10.45 a.m.    Break

Genetics of Inherited Thyroid Cancer
                                                Albert de la Chapelle, MD, PhD

11:25-12:00 p.m.       Genetics-Driven Approach to Medullary Thyroid Cancer Management            
Rebecca Nagy, CGC, MD

12:15 p.m.                 Lunch with the Professor 
1.  Ricardo Carrau, MD - Management of Salivary Gland Dysfunction ater I-131
2.  Amit
t Agrawal, MD Intraoperative Imaging and Sentinal Nodes in Recurrent Thyroid Cancer Surgery
3. Lawrence Kirschner, MD, PhD -
4.  Matthew Ringel, MD - Medullary Thyroid Cancer Management: Case-based Discussion
SESSION TWO: Thyroid Cancer Management

SESSION CHAIR: Jennifer Sipos, MD
     Current Concepts in the Management of Differentiated and Medullary Thyroid Cancer
1:10 p.m.                  In Memoriam: Ernest Mazzaferri Plaque Presentation
                                         Hossein Gharib, MD
2:10-2:45 p.m.         Approach to the Patient with Anti-thyroglobulin Antibodies
                                         Fadi Nabhan, MD
2:50-3:20 p.m.         Case-based Panel Discussion:  Controversies in thyroid cancer surgery
                                          Moderator:  Jennifer Sipos, MD
                                          Panelists:  William Farrar, MD, John Phay, MD and Ted Teknos, MD
3:25 p.m.                  Afternoon Break 
Management of Radioiodine Refractory Thyroid Cancer
                                        Jennifer Sipos, MD                         
4:15-4:50 p.m.         Systemic Therapies: Current Status and Future Directions
                                        Manisha Shah, MD
4:50-4:55 p.m.         Questions
5:00 p.m.                 Concluding Remarks, Evaluation and Adjourn    


The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: